Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
ID: 332516Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/332516

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-21-201.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for research on Autism Spectrum Disorders (ASD) through the R01 Clinical Trial Optional grant mechanism. This initiative aims to support research that elucidates the etiology, epidemiology, diagnosis, and optimal service delivery methods related to ASD, emphasizing the importance of preliminary data in applications. The funding is intended to foster innovative studies addressing critical public health questions, including genetic and environmental influences on ASD, with a maximum project duration of five years. Interested applicants, including various educational institutions and community organizations, must submit their proposals by January 25, 2025, and can find further details at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.

    Point(s) of Contact
    FBOWebmaster@OD.NIH.GOV
    Files
    Title
    Posted
    PA-21-201-Full-Announcement.html
    PA-21-201.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), released a Funding Opportunity Announcement (FOA) aimed at fostering research on Autism Spectrum Disorders (ASD). This initiative is encapsulated under the R01 Research Project Grant mechanism, which encourages investigations into the etiology, epidemiology, diagnosis, and service delivery related to ASD. The FOA emphasizes the need for preliminary data in applications and invites research that addresses critical public health questions, aiming to enhance understanding of the disorder's complex nature, including its potential genetic and environmental influences. Eligible applicants include various educational institutions, nonprofits, and governmental entities, with an emphasis on diversity and inclusion efforts. The funding aims to promote innovative studies in areas such as epidemiology, early screening, genomic research, brain mechanisms, and services delivery related to ASD. The application process requires strict adherence to NIH guidelines with a maximum project duration of five years. The announcement specifies various due dates for grant submissions and highlights that funding availability depends on appropriations and merit of applications. Overall, this initiative underscores the NIH's commitment to advancing autism research and improving outcomes for affected individuals.
    Similar Opportunities
    Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research on Autism Spectrum Disorders (ASD) through the R21 grant mechanism, aimed at elucidating the etiology, epidemiology, diagnosis, and service delivery methods related to ASD. This initiative encourages exploratory and developmental research without the need for preliminary data, allowing for innovative studies on genetic and environmental factors, early diagnosis, brain mechanisms, and cognitive skills. The total budget for projects is capped at $275,000 over two years, and applications are accepted from a wide range of eligible entities, including educational institutions and nonprofit organizations. Interested applicants must submit their proposals electronically via Grants.gov by November 16, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)" aimed at promoting research on Autism Spectrum Disorders (ASD). This initiative encourages applications that investigate various aspects of ASD, including its etiology, epidemiology, diagnosis, and service delivery methods, through small, well-defined projects that can be completed within two years. The R03 grant program is particularly significant as it addresses a critical public health issue affecting many individuals and families, allowing for both clinical and non-clinical trials without the requirement for preliminary data in pilot studies. Interested applicants can apply for grants of up to $50,000, with the application deadline set for November 16, 2024. For further details, applicants may contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-21-199.html.
    Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research into the natural history of disorders detectable through newborn screening, under the grant title "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)." This initiative aims to enhance understanding of these disorders to support early identification and intervention, focusing on improving diagnostic accuracy, elucidating genetic and clinical heterogeneity, and exploring underlying mechanisms to inform treatment options. The funding is available for new, renewal, resubmission, or revision applications, with a maximum support period of five years and no cost-sharing requirement. Interested applicants, including various educational and community organizations, must submit proposals by January 7, 2025, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance or further information.
    Research Project Grant (Parent R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Research Project Grant (Parent R01 Clinical Trial Required) to support specified clinical research projects that align with the missions of various NIH institutes. Applicants are required to propose at least one clinical trial, focusing on significant health-related research areas, and must comply with the NIH Grants Policy Statement. This funding opportunity is crucial for advancing medical science and improving patient care, emphasizing innovation and scientific merit in addressing important health issues. The application deadline is January 7, 2025, and interested parties can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries. More details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-20-183.html.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," aimed at encouraging research into novel screening methods and therapeutic interventions for serious genetic and congenital conditions identified through newborn screening. This initiative, under the R03 Small Grant Program, supports small-scale projects lasting up to two years with a budget of up to $50,000 per year, focusing on developing robust screening technologies to enhance early detection and treatment of disorders, thereby minimizing long-term health consequences. The program is particularly important for addressing high-priority conditions where screening is not currently recommended, and it emphasizes inclusivity in research by inviting applications from a diverse range of organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is November 16, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the funding opportunity titled "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)," aimed at advancing research on the biological mechanisms underlying complex brain disorders such as schizophrenia, bipolar disorder, and autism. This initiative encourages studies that explore high-confidence risk factors associated with these disorders, focusing on intracellular, transcellular, and circuit mechanisms, while emphasizing the importance of disseminating findings to enhance data resources and therapeutic target identification. Eligible applicants include a wide range of institutions, including historically black colleges, tribal colleges, and various nonprofit organizations, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and detailed information can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-024.html.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for innovative research aimed at developing screening approaches and therapies for screenable disorders in newborns, designated as R21 - Clinical Trial Optional. This initiative encourages projects that focus on creating novel screening techniques and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening, particularly emphasizing early diagnosis and treatment to improve health outcomes. The program is part of NIH's commitment to advancing public health and reducing health disparities, with a funding ceiling of $275,000 available over a two-year period. Interested applicants, including a diverse range of institutions and organizations, must submit their proposals by November 16, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Autism Research Consortium
    Active
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Autism Research Consortium," aimed at establishing a consortium of research institutions to enhance the evidence base for effective interventions and services for children and adolescents with autism and other developmental disabilities. Eligible applicants include public and private entities, such as research centers, faith-based organizations, and tribal entities, with no cost-sharing or matching requirements. This initiative is critical for advancing health services and support systems for affected populations, with an estimated total program funding of $4.8 million and an award ceiling of $960,000 for up to five awards. Interested parties can reach out to Deborah Quint Shelef and Emmie Perchak at AutismRC@hrsa.gov or by phone at (240) 460-5221, with proposals expected to be submitted by March 10, 2025, and project start dates anticipated for September 1, 2025.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for research titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," aimed at developing novel screening techniques and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. This initiative encourages diverse scientific research focused on improving screening technologies, therapeutic interventions, and preclinical testing, particularly for "high priority" genetic conditions that are not currently recommended for screening but could benefit from early identification and treatment. Eligible applicants include a wide range of organizations, such as educational institutions, community-based organizations, and tribal governments, with applications due by November 5, 2024. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-21-353.html.
    Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) to support basic experimental studies involving human participants. This funding opportunity is aimed at projects that explore fundamental aspects of phenomena without specific applications in mind, emphasizing studies that prospectively assign human participants to conditions and assess biomedical or behavioral outcomes. The grant is open to a diverse range of eligible applicants, including educational institutions, nonprofits, and certain businesses, with no budget limits set, although expenses must align with actual project needs. Applications must be submitted electronically by January 7, 2025, and further details can be found at the provided NIH link or by contacting the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.